Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases.

Rheumatology (Oxford, England) - 1 May 2025

Blanco Ricardo, Aldasoro Vicente, Maiz Olga, Melero Rafael, Romero-Yuste Susana, de Miguel Eugenio, Ferraz-Amaro Iván, López-Gutiérrez Fernando, Castañeda Santos, Loricera Javier

Abstract excerpt

OBJECTIVE: The spectrum of GCA includes various vascular phenotypes. Tocilizumab (TCZ) is the only biologic therapy currently approved, regardless of phenotype. We aimed to assess the effectiveness of TCZ in various phenotypes. METHODS: This is a multicentre observational study of GCA patients treated with TCZ. They were divided into three phenotypes: (i) cranial (cGCA), (ii) extracranial GCA (ecGCA) and (iii)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Monoclonal, Humanized

Share to GCA gene

Share to Giant Cell Arteritis

Share to Phenotype

Share to Remission Induction

Share to Treatment Outcome

Source

Identifiers

PMID: 39658241
DOI: 10.1093/rheumatology/keae666

Genes

GCA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases.PMID 39658241Read ↗

Clinical phenotype and complications of large vessel giant cell arteritis: A systematic review and meta-analysis.Semantic proximity Read ↗

Clinical Phenotypes of Giant Cell Arteritis: Insights into Complications and Survival OutcomesSemantic proximity Read ↗

Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease.Semantic proximity Read ↗

Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry.Semantic proximity Read ↗

Takayasu arteritis and giant cell arteritis: are they a spectrum of the same disease?Semantic proximity Read ↗

Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes.Semantic proximity Read ↗

Comparative analysis of arterial involvement in predominant cranial and isolated extracranial phenotypes of giant cell arteritis using 18F-FDG PET-CT.Semantic proximity Read ↗

Giant cells in temporal artery biopsies are associated with a reduced risk of large vessel involvement in patients with giant cell arteritis : a retrospective cohort studySemantic proximity Read ↗

Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association.Semantic proximity Read ↗

Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013–2020Semantic proximity Read ↗

PET-CT spectrum of large vessel vasculitis (LVV) in a tertiary center: differences in FDG uptake between LVV with predominant cranial and extracranial giant cell arteritis phenotypesSemantic proximity Read ↗

Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.